Table 3

Comparison of clinical parameters between the group with end stage renal disease and the controls

North AfricanPalestinian Arabs
AmyloidControlAmyloidControl
Age3-150 (mean (SD))45.7 (7.6)44.7 (7.3)40.1 (11.3)38.9 (11.1)
Age at onset of FMF6.0 (4.1)6.6 (3.7)11.7 (7.1)10.4 (5.4)
Disease duration3-151 27.2 (8.2)27.9 (5.9)19.3 (8.9)24.7 (8.2)

  • ↵3-150 Age at the time of the study.

  • ↵3-151 In patient with amyloid: duration until renal failure. In controls: duration of the disease until the time of this study.